Response to "Letter to the Editor Regarding a Multicenter Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia"

被引：0
|
作者：
Mantelli, Flavio [1 ]
机构：
[1] Dompe Farmaceut SpA, Via Santa Lucia 6, I-20122 Milan, Italy
来源：
INFECTIOUS DISEASES AND THERAPY | 2023年 / 12卷 / 01期
关键词：
D O I：
10.1007/s40121-022-00727-4
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：301 / 302
页数：2
相关论文
共 50 条
  • [31] Efficacy and safety of Treamid in the rehabilitation of patients after COVID-19 pneumonia: a phase 2, randomized, double-blind, placebo-controlled trial
    Evgeny Bazdyrev
    Maria Panova
    Maria Brachs
    Elena Smolyarchuk
    Daria Tsygankova
    Liudmila Gofman
    Yana Abdyusheva
    Fedor Novikov
    Journal of Translational Medicine, 20
  • [32] Efficacy of clarithromycin in patients with mild COVID-19 pneumonia patients: An exploratory, multicenter, open-label, randomized controlled trial
    Yamamoto, Kazuko
    Fukuda, Yuichi
    Sawai, Toyomitsu
    Ide, Shotaro
    Mori, Yusuke
    Hashiguchi, Kohji
    Ishii, Hiroshi
    Futsuki, Yoji
    Iwanaga, Naoki
    Hosogaya, Naoki
    Sakamoto, Noriho
    Yoshida, Haruo
    Takamatsu, Yuki
    Ota, Kenji
    Izumikawa, Koichi
    Yanagihara, Katsunori
    Mukae, Hiroshi
    RESPIROLOGY, 2023, 28 : 226 - 226
  • [33] Evaluation of convalescent plasma versus standard of care for the treatment of COVID-19 in hospitalized patients: study protocol for a phase 2 randomized, open-label, controlled, multicenter trial
    Diago-Sempere, Elena
    Bueno, Jose Luis
    Sancho-Lopez, Aranzazu
    Rubio, Elena Munez
    Torres, Ferran
    de Molina, Rosa Malo
    Fernandez-Cruz, Ana
    de Diego, Isabel Salcedo
    Velasco-Iglesias, Ana
    Payares-Herrera, Concepcion
    Flecha, Inmaculada Casas
    Avendano-Sola, Cristina
    Palomino, Rafael Duarte
    Ramos-Martinez, Antonio
    Ruiz-Antoran, Belen
    TRIALS, 2021, 22 (01)
  • [34] Evaluation of convalescent plasma versus standard of care for the treatment of COVID-19 in hospitalized patients: study protocol for a phase 2 randomized, open-label, controlled, multicenter trial
    Elena Diago-Sempere
    José Luis Bueno
    Aránzazu Sancho-López
    Elena Múñez Rubio
    Ferrán Torres
    Rosa Malo de Molina
    Ana Fernández-Cruz
    Isabel Salcedo de Diego
    Ana Velasco-Iglesias
    Concepción Payares-Herrera
    Inmaculada Casas Flecha
    Cristina Avendaño-Solà
    Rafael Duarte Palomino
    Antonio Ramos-Martínez
    Belén Ruiz-Antorán
    Trials, 22
  • [35] Lack of efficacy of hydroxychloroquine and azithromycin in patients hospitalized for COVID-19 pneumonia: A retrospective study
    Saib, Anis
    Amara, Walid
    Wang, Pascal
    Cattan, Simon
    Dellal, Azeddine
    Regaieg, Kais
    Nahon, Stephane
    Nallet, Olivier
    Nguyen, Lee S.
    PLOS ONE, 2021, 16 (06):
  • [36] Efficacy and Safety of Lianhua Qingke Tablets in the Treatment of Mild and Common-Type COVID-19: A Randomized, Controlled, Multicenter Clinical Study
    Zhang, Ling
    Wu, Lei
    Xu, Xiaolong
    Yuan, Yadong
    Jiang, Rongmeng
    Yan, Xixin
    Zhang, Xin
    Gao, Yong
    Shang, Huanxia
    Lian, Bo
    Hu, Jing
    Mei, Jianqiang
    Wu, Shucai
    Liu, Qingquan
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [37] Therapeutic versus Prophylactic Bemiparin in Hospitalized Patients with Nonsevere COVID-19 Pneumonia (BEMICOP Study): An Open-Label, Multicenter, Randomized, Controlled Trial
    Marcos-Jubilar, Maria
    Carmona-Torre, Francisco
    Vidal, Rosa
    Ruiz-Artacho, Pedro
    Filella, David
    Carbonell, Cristina
    Jimenez-Yuste, Victor
    Schwartz, Juana
    Llamas, Pilar
    Alegre, Felix
    Sadaba, Belen
    Nunez-Cordoba, Jorge
    Yuste, Jose R.
    Fernandez-Garcia, Javier
    Lecumberri, Ramon
    THROMBOSIS AND HAEMOSTASIS, 2022, 122 (02) : 295 - 299
  • [38] Safety and efficacy of favipiravir in COVID-19 patients with pneumonia. A randomized, double-blind, placebo-controlled study (FAVID)
    Juan P. Horcajada
    Rebeca Aldonza
    Mónica Real
    Silvia Castañeda-Espinosa
    Elena Sendra
    Joan Gomez-Junyent
    Inmaculada López-Montesinos
    Silvia Gómez-Zorrilla
    Silvia Briansó
    Montserrat Duran-Taberna
    Andrés Fernández
    Cristina Tarragó
    Teresa Auguet-Quintillá
    Pneumonia, 16
  • [39] Enpatoran in COVID-19 pneumonia: Safety and efficacy results from a phase II randomized trial
    Mckinnon, John E.
    Santiaguel, Joel
    de Oliveira, Claudia Murta
    Yu, Dongzi
    Khursheed, Mukhy
    Moreau, Flavie
    Klopp-Schulze, Lena
    Shaw, Jamie
    Roy, Sanjeev
    Kao, Amy H.
    ANEMONE Study Team
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (12): : 2640 - 2653
  • [40] Safety and efficacy of favipiravir in COVID-19 patients with pneumonia. A randomized, double-blind, placebo-controlled study (FAVID)
    Horcajada, Juan P.
    Aldonza, Rebeca
    Real, Monica
    Castaneda-Espinosa, Silvia
    Sendra, Elena
    Gomez-Junyent, Joan
    Lopez-Montesinos, Inmaculada
    Gomez-Zorrilla, Silvia
    Brianso, Silvia
    Duran-Taberna, Montserrat
    Fernandez, Andres
    Tarrago, Cristina
    Auguet-Quintilla, Teresa
    PNEUMONIA, 2024, 16 (01)
12345